Dianwen B. Han
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
FBXW5 blunts RIGI/MDA5-IFN signaling to drive immunoevasion and chemo-immune resistance in triple-negative breast cancer models.
Journal: The Journal of clinical investigation
Published: August 25, 2026
Cancer-Associated Fibroblasts Promote Glucose Metabolic Reprogramming and Progression of Triple-Negative Breast Cancer via Exosomal circFAD104-Mediated Intercellular Communication.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 05, 2026
circZNF148 Drives Glucose Metabolism Reprogramming to Enhance Metastasis and Immune Evasion via HK1 Stabilization in Triple-Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 09, 2026
CircKIAA1617 promotes stemness via USP14/PGRMC1-mediated autophagy and lipid metabolism reprogramming in ER-positive breast cancer.
Journal: Molecular cancer
Published: September 09, 2025
TRIM38 Suppresses Breast Cancer Progression via Modulating SQSTM1 Ubiquitination and Autophagic Flux.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 09, 2025
A novel peptide MIB1-223aa encoded by exosomal circMIB1 from cancer-associated fibroblasts drives triple-negative breast cancer metastasis and stemness via stabilizing MIB1 to activate Notch signaling.
Journal: Journal of advanced research
Published: January 12, 2025
The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor response.
Journal: Cell death and differentiation
Published: November 06, 2024
EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer.
Journal: Research (Washington, D.C.)
Published: October 01, 2024
UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation.
Journal: Translational oncology
Published: August 26, 2024
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation-Mediated c-Myc Deubiquitylation to Facilitate Mutant TP53 Transcription.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 29, 2024
Last Updated: 09/26/2026